InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:InteRNA Technologies BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013989
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing miRNA-based therapeutics which controls genes connected in signal transduction pathways. InteRNA’s technologies comprise deep sequencing and bioinformatics, miRNA expression database, data analyses platform, and lentiviral-based miRNA overexpression library. The company specializes in oncology programs including in vivo proof of concept for non-formulated anti-miRNA mimics, demonstrating significant tumor suppression in a mouse tumor xenograft model and development of a miRNA compound for mutant B-Raf associated solid tumors. InteRNA is headquartered in Nijmegen, the Netherlands.

InteRNA Technologies BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
InteRNA Technologies BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
InteRNA Technologies BV, Medical Devices Deals, 2011 to YTD 2017 9
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
InteRNA Technologies Raises Additional Funds in Series A Financing 11
InteRNA Technologies Raises Funds Through Venture Financing 12
Partnerships 13
InteRNA Technologies Enters into Agreement with Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung 13
Silence Therapeutics Enters Into Co-Development Agreement With InteRNA Technologies 14
InteRNA Technologies BV – Key Competitors 15
InteRNA Technologies BV – Key Employees 16
InteRNA Technologies BV – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Key Facts 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
InteRNA Technologies BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
InteRNA Technologies BV, Deals By Therapy Area, 2011 to YTD 2017 8
InteRNA Technologies BV, Medical Devices Deals, 2011 to YTD 2017 9
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
InteRNA Technologies Raises Additional Funds in Series A Financing 11
InteRNA Technologies Raises Funds Through Venture Financing 12
InteRNA Technologies Enters into Agreement with Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung 13
Silence Therapeutics Enters Into Co-Development Agreement With InteRNA Technologies 14
InteRNA Technologies BV, Key Competitors 15
InteRNA Technologies BV, Key Employees 16
InteRNA Technologies BV, Other Locations 17

★海外企業調査レポート[InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arcadis N.V.:企業のM&A・事業提携・投資動向
    Arcadis N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arcadis N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Under Armour, Inc.:企業の戦略・SWOT・財務情報
    Under Armour, Inc. - Strategy, SWOT and Corporate Finance Report Summary Under Armour, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Horizon Therapeutics Plc (HZNP):企業の財務・戦略的SWOT分析
    Horizon Therapeutics Plc (HZNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Minor International PCL:企業の戦略・SWOT・財務情報
    Minor International PCL - Strategy, SWOT and Corporate Finance Report Summary Minor International PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tejas Networks Ltd (TEJASNET):企業の財務・戦略的SWOT分析
    Tejas Networks Ltd (TEJASNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • GenePOC Inc-医療機器分野:企業M&A・提携分析
    Summary GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a no …
  • Menssana Research Inc:企業の製品パイプライン分析2018
    Summary Menssana Research Inc (Menssana) is a medical device development company that develops breath test systems. The company offers BreathLink a cloud application that concentrates, collects, and analyzes organic compounds in human breath. It also provides Breathscanner a mobile point of care sys …
  • TBC Insurance JSC:企業の戦略的SWOT分析
    TBC Insurance JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Sunningdale Tech Ltd (BHQ):企業の財務・戦略的SWOT分析
    Summary Sunningdale Tech Ltd (Sunningdale) is a chemical company that manufactures and markets tooling and plastic injection moulding components. The company's plastic solutions include product and mould designs, injection moulding, mould fabrication, complementary finishings, and precision assembly …
  • Neurodyn Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurodyn Life Sciences Inc (Neurodyn Life Sciences), formerly Neurodyn Inc is a provider of validation and development of bioactives for neuroprotection and early treatment of neurological diseases. The company's products include neuroprotectant, memogain, progranulin, and nerve pain treatme …
  • UTStarcom Holdings Corp. (UTSI):企業の財務・戦略的SWOT分析
    UTStarcom Holdings Corp. (UTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Qiagen NV (QIA)-製薬・医療分野:企業M&A・提携分析
    Summary Qiagen NV (Qiagen) is a provider of molecular testing solutions. Its solutions include sample and assay technologies, bioinformatics and automation systems. Qiagen’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue. The company’s produc …
  • Covance Inc:医療機器:M&Aディール及び事業提携情報
    Summary Covance Inc (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research and manufacturing services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. I …
  • Arla Foods Ingredients Group P/S:戦略・SWOT・企業財務分析
    Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report Summary Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Transcatheter Technologies GmbH-医療機器分野:企業M&A・提携分析
    Summary Transcatheter Technologies GmbH (Transcatheter) is a medical equipment company that develops aortic valve implantation system. The company develops technologies for self-expanding valve prostheses and endovascular stents through inner catheters. It develops aortic valve implantation system f …
  • Aldi Inc:企業の戦略的SWOT分析
    Aldi Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Vostok New Ventures Ltd (VNV SDB):企業の財務・戦略的SWOT分析
    Summary Vostok New Ventures Ltd (Vostok New Ventures), formerly Vostok Nafta Investment Ltd, is an investment company that identifies and invests in assets. The company carries out partial and complete liquidation of holding and group’s holding companies. It identifies and invests in unlisted compan …
  • RPC Group Plc (RPC):企業の財務・戦略的SWOT分析
    RPC Group Plc (RPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Park Electrochemical Corp (PKE):企業の財務・戦略的SWOT分析
    Summary Park Electrochemical Corp (Park Electrochemical) is a technology company that develops and manufactures high technology digital and radio frequency and microwave printed circuit materials. The company provides advanced composite materials in product forms such as broadgoods, unidirectional t …
  • CorMatrix Cardiovascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary CorMatrix Cardiovascular Inc (CorMatrix) is a medical device company that offers biomaterial devices. The company’s products comprise interim bioscaffolds, cardiovascular devices, biomaterials, cardiovascular medical devices, extracellular matrix materials, cardiovascular surgery devices, cr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆